Election 2014
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 17, 17:00
2556.00
16.65 (0.66%)
VOLUME 15,558
LIVE
NSE
Apr 17, 12:17
2538.00
1.25 (0.05%)
VOLUME 105,182
News on Dr Reddys Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's launches Eszopiclone Tablets C-IV

10.18 am | 16 Apr 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched Eszopiclone Tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA tablets C-IV ...

Lupin pulls over 9,000 bottles of anti-infective Suprax

2.16 pm | 15 Apr 2014 |  Source: Reuters

The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year b...

Religare expects Q4 to be mixed-bag, picks top sector bets 

11.56 am | 12 Apr 2014 |  Source: CNBC-TV18

Tirthankar Patnaik bearish on financials and public sector lenders, but State Bank of India is the stock from the PSB pack which he likes....

Dr Reddys Labs: FY14 results on May 13, 2014

8.40 pm | 11 Apr 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories board meeting will be held on May 13, 2014, to consider and approve the Audited Financial Results of the Company for the financ...

Pharma cos may see healthy earnings growth in Q4FY14: CLSA

12.36 pm | 03 Apr 2014 |  Source: Moneycontrol.com

Most companies are expected to report some forex gains on hedges and foreign liabilities given the slight strengthening of rupee Q-o-Q, CLSA said....

Super Six: Top chart picks for today 

8.33 am | 02 Apr 2014 |  Source: CNBC-TV18

Shrikant Chouhan of Kotak Securities advises buying Tata Motors with a target of Rs 410-415 and Dr Reddy's Laboratories with a target of Rs 2660-2670....

Exit Dr Reddy's Laboratories, says Kunal Bothra 

4.39 pm | 31 Mar 2014 |  Source: CNBC-TV18

Kunal Bothra, head of advisory at LKP advises exiting Dr Reddy's Laboratories....

Stocks in news: Sun Pharma, Unitech, Suzlon, Tech Mah, PNB

8.26 am | 28 Mar 2014 |  Source: CNBC-TV18

Sun Pharma | Colgate Palmolive | Canara Bank | Infosys | MCX | Lakshmi Vilas Bank | Unitech | Punjab National Bank | Claris Life Sciences | Godrej Pro...

Dr Reddy's launches generic cholesterol-lowering drug in US

6.59 pm | 27 Mar 2014 |  Source: PTI

The company's product is the generic equivalent of Pfizer Inc's Caduet tablets, it added. The Hyderabad-based firm's Amlodipine Besylate and Atorvasta...

Dr Reddys launched Amlodipine Besylate and Atorvastatin calcium tablets

10.22 am | 27 Mar 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched Amlodipine Besylate and Atorvastatin Calcium Tablets, a therapeutic equivalent generic version of CADUET tablets, ...

Here’s how market performed during UPA-2 regime 

10.37 pm | 26 Mar 2014 |  Source: CNBC-TV18

Since the UPA-2 came to power, wealth creation on the NSE stands at 35 lakh crore rupees with the nifty gaining 80 percent. But in dollar terms, that'...

India generic drugmakers' woes put new focus on quality

8.42 am | 26 Mar 2014 |  Source: Reuters

In the short term, that is expected to benefit larger global competitors, such as Teva Pharmaceutical Industries Ltd, Actavis Plc and Mylan Inc, which...

Dr Reddy's Lab recalls 58,656 bottles of Lansoprazole in US

7.10 pm | 13 Mar 2014 |  Source: PTI

The US Food and Drug Administration has classified the recall of the drug as 'Class II' which indicates a remote chance of severe adverse consequences...

Dr Reddy's recalls some lots of heartburn drug in U.S

3.31 pm | 13 Mar 2014 |  Source: Reuters

It was classified as a "Class II" recall which indicates a remote chance of severe adverse consequences or death due to the product flaw....

Buy Dr Reddys Laboratories; target Rs 3180: Motilal Oswal

5.15 pm | 12 Mar 2014 |  Source: Moneycontrol.com

Brokerage house Motilal Oswal is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 3180, in its ...

Prefer Cipla, Sun Pharma, Dr Reddys: Phani Sekhar 

4.10 pm | 10 Mar 2014 |  Source: CNBC-TV18

According to Phani Sekhar of Angel Broking, one may prefer Cipla, Sun Pharmaceuticals and Dr Reddy’s Laboratories in pharma space....

6850 on Nifty likely; be cautious & buy on dips: Ajay Bodke 

10.00 am | 10 Mar 2014 |  Source: CNBC-TV18

According to Ajay Bodke, Prabhudas Lilladher one should clearly watch out for the forthcoming events of the week that is the Crimean referendum on Mar...

Top 10 stocks to focus on March 10 

9.27 am | 10 Mar 2014 |  Source: CNBC-TV18

According to CNBC-TV18’s research team following are the stocks to focus on Dr Reddy's, BPCL, Ranbaxy, Dishman Pharma, Bank of Baroda, Ashok Leyland...

BioAsia 2014: A holistic approach to product innovation 

4.47 pm | 08 Mar 2014 |  Source: CNBC-TV18

Companies from across the globe come together to pull in ideas and resources for sustainable and viable biotech innovations. It may sound technical, b...

Buy Dr Reddys Laboratories; target of Rs 3239: ICICIdirect

2.56 pm | 06 Mar 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Dr Reddys Laboratories (DRL) and has recommended buy rating on the stock with a target price of Rs 3239, in its research...

1 2 3 4
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.